News
Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...
Narrator We asked professor of pharmacy, Michell Redding to give a tutorial on how to interpret the drug facts label. The "active ingredient" is listed first: Michell Redding, Pharm.D. The active ...
After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda ...
Camzyos is an oral, selective allosteric and reversible inhibitor of cardiac myosin. It was approved in April 2022 for the treatment of adults with symptomatic New York Heart Association (NYHA) class ...
Label updates include simplified twice-yearly echo monitoring for eligible CAMZYOS patients in the maintenance phase and expanded patient eligibility with reduced contraindication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results